Literature DB >> 25626436

Contribution of opiates in sudden asthma deaths.

Leigh Hlavaty1, Patrick Hansma, LokMan Sung.   

Abstract

Asthma is a common disease in the United States and is frequently encountered during medicolegal autopsies. Patients are often young and have a witnessed collapse or are found dead. Opiate abuse is also pervasive and is repeatedly seen in death investigations. All cases over a 7-year period involving asthma investigated at the Wayne County Medical Examiner's Office were reviewed for demographics, circumstances, autopsy toxicology findings, and cause and manner of death. Ninety-four cases met these criteria. Ten cases (10.5%) were positive for opiates, 8 listed drugs as the cause of death, and 2 listed asthma. Of cases with established asthma opiate positivity, 8 (80%) were found dead, and only one had a witnessed collapse. Compared with those without opiate abuse, asthmatic patients abusing opiates had a higher mean age, no reported respiratory symptoms immediately preceding death, and higher frequency of being found dead. A discernable difference exists between deaths in asthmatic patients in the presence of opiates and those without. These findings indicate that it may be possible to predict the presence of opiates given history investigation information, thereby focusing toxicology panels to promote cost-effective practices when ordering supportive tests.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25626436     DOI: 10.1097/PAF.0000000000000138

Source DB:  PubMed          Journal:  Am J Forensic Med Pathol        ISSN: 0195-7910            Impact factor:   0.921


  2 in total

Review 1.  [Asthma and heroin use].

Authors:  Michel Underner; Jean Perriot; Gérard Peiffer; Nematollah Jaafari
Journal:  Presse Med       Date:  2017-07-20       Impact factor: 1.228

Review 2.  [Asthma and cannabis, cocaine or heroin use].

Authors:  M Underner; G Peiffer; J Perriot; N Jaafari
Journal:  Rev Mal Respir       Date:  2020-07-08       Impact factor: 0.622

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.